The design of multi-target ligands and their role in schizophrenia therapy: an update

Zarko Gagic, Marija Popovic-Nikolic, Marija Carapic, Selma Zukic, Slavica Oljacic, Katarina Nikolic

Open source

DOI
10.1080/17460441.2026.2669617
Published
2026-05-08
Container
Expert Opinion on Drug Discovery
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17460441.2026.2669617,
  title = {The design of multi-target ligands and their role in schizophrenia therapy: an update},
  author = {Zarko Gagic and Marija Popovic-Nikolic and Marija Carapic and Selma Zukic and Slavica Oljacic and Katarina Nikolic},
  year = {2026},
  journal = {Expert Opinion on Drug Discovery},
  doi = {10.1080/17460441.2026.2669617},
  url = {https://doi.org/10.1080/17460441.2026.2669617}
}

RIS

TY  - JOUR
TI  - The design of multi-target ligands and their role in schizophrenia therapy: an update
AU  - Zarko Gagic
AU  - Marija Popovic-Nikolic
AU  - Marija Carapic
AU  - Selma Zukic
AU  - Slavica Oljacic
AU  - Katarina Nikolic
PY  - 2026
JO  - Expert Opinion on Drug Discovery
DO  - 10.1080/17460441.2026.2669617
UR  - https://doi.org/10.1080/17460441.2026.2669617
ER  - 

APA

Gagic, Z., Popovic-Nikolic, M., Carapic, M., Zukic, S., Oljacic, S., & Nikolic, K. (2026). The design of multi-target ligands and their role in schizophrenia therapy: an update. Expert Opinion on Drug Discovery. https://doi.org/10.1080/17460441.2026.2669617

Source records